Succinylcholine Completed Phase 4 Trials for Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01907217Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression